Alphabet’s drug-discovery spinout is chasing a $40B-plus valuation, and this frog wants in before the lab coats do.
Catalyst. 'Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value' - Bloomberg
Bloomberg reports Alphabet’s Isomorphic Labs is in funding talks at a valuation of at least $40 billion, creating a concrete AI drug-discovery financing catalyst for GOOGL.
70% of this token's trading fees go to the wallet that deployed it. 30% buys back and burns $BOTIFY.